PUBLICATIONS AND PRESENTATIONS

Updated November 2025 (full resume available upon request)

Opere CA (Medical Writing: Giara K). Achieving Improved Ocular Surface Health in Dry Eye Disease: A Pharmacy-Focused Review at the Forefront of a New Treatment Era. November 10, 2025. Available at https://www.powerpak.com/course/preamble/138888 (Expires November 10, 2026)

Giara K. Patient Safety: Migraine Management Essentials: From Aura to Action. Presented live November 8, 2025. National Pharmacy Technician Association: CPhT Live 2025.

Giara K. Semaglutide Wins Cardiovascular Approval as FDA's Obesity Review Nears. October 21, 2025. Available at https://www.medcentral.com/endocrinology/diabetes/semaglutide-wins-cv-nod-as-approval-as-the-first-oral-glp-1-for-obesity-nears

Giara K. Ask the PharmD: Which OTC supplements raise red flags? October 17, 2025. Available at https://www.medcentral.com/meds/which-otc-supplements-raise-red-flags

Giara K. Treatment Guide to Remibrutinib for Chronic Spontaneous Urticaria. October 16, 2025. Available at https://www.medcentral.com/drugs/guide/remibrutinib

Amibizas EM (Medical Writing: Giara K). Enhancing Awareness and Improving Care in Open-Angle Glaucoma: A Clearer Look at the Role of Rho Kinase Inhibition. September 12, 2025. Available at https://www.powerpak.com/course/preamble/126967 (Expires September 12, 2026)

Rich SJ (Medical Writing: Giara K). Novel Mechanisms, Novel Solutions: Managed Care Strategies for Non-Opioid Acute Pain Management. August 29, 2025. Available at https://www.powerpak.com/course/preamble/126870 (Expires August 29, 2026)

Giara K. Ask the PharmD: How can I best utilize a specialty pharmacy to improve patient care? August 22, 2025. Available at https://www.medcentral.com/meds/how-can-i-best-utilize-a-specialty-pharmacy-to-improve-patient-care

Giara K. FDA Approval of Cyclobenzaprine HCL Aims to Combat Fibromyalgia Pain. August 15, 2025. Available at https://www.medcentral.com/rheumatology/fibromyalgia/fda-approves-cyclobenzaprine-for-fibromyalgia

Giara K. FDA Greenlights KETARx for Surgical Pain Amid Long-Standing Ketamine Shortage. August 14, 2025. Available at https://www.medcentral.com/meds/opioids/postsurgical/fda-approves-ketarx-ketamine-for-surgical-pain

Giara K. FDA Approval of Brensocatib Marks First Therapy for Bronchiectasis. August 12, 2025. Available at https://www.medcentral.com/pulmonology/fda-approves-brensocatib-for-non-cystic-fibrosis-bronchieactasis

Giara K (Medical Reviewer: DiPierro N). Patient Guide to Avapritinib (Ayvakit) for SM and GIST. August 7, 2025. Available at https://www.patientpower.info/drugs/guide/avapritinib-for-sm-and-gist

Lusk KA (Medical Writing: Giara K). Strike When the Iron is “Not”: How to Identify and Manage Iron Deficiency Across a Range of Patients and Disease States. July 31, 2025. Available at https://www.powerpak.com/course/preamble/126651 (Expires July 31, 2026)

Giara K. Treatment Guide for Tirzepatide (Zepbound) for Obesity or Overweight. July 8, 2025. Available at https://www.medcentral.com/drugs/guide/tirzepatide

Giara K. Treatment Guide for Prescribing Anifrolumab-fnia (Saphnelo) for Systemic Lupus Erythematosus. July 1, 2025. Available at https://www.medcentral.com/drugs/guide/anifrolumab-fnia

Giara K. Treatment Guide for Belimumab (Benlysta) for Systemic Lupus Erythematosus. July 1, 2025. Available at https://www.medcentral.com/drugs/guide/belimumab

Giara K. Which drugs commonly cause constipation? June 17, 2025. Available at https://www.medcentral.com/meds/which-drugs-commonly-cause-constipation

Giara K. GSK's Nucala Finally Gets FDA Approval for COPD. May 23, 2025. Available at https://www.medcentral.com/pulmonology/copd/fda-decision-on-GSK-indication-mepolizumab-for-copd

Giara K. FDA Approves First Alzheimer’s Diagnostic Blood Test. May 19, 2025. Available at https://www.medcentral.com/neurology/dementia/fda-approves-first-alzheimers-diagnostic-blood-test

Giara K. Treatment Guide for Donanemab-azbt (Kisunla) for Alzheimer’s Disease. May 1, 2025. Available at https://www.medcentral.com/drugs/guide/donanemab-azbt

Bridgeman MB, Walter JM (Medical Writing: Giara K). Transforming Asthma Management: The Role of Pharmacists in Implementing Combination Therapy. April 30, 2025. Available at https://www.powerpak.com/course/preamble/125975 (Expires April 30, 2026)

Giara K. FDA Approves First Nasal Formulation of Dihydroergotamine for Migraine. April 30, 2025. Available at https://www.medcentral.com/neurology/migraine/fda-approves-satsuma-dihydroergotamine-nasal-powder-for-migraine

Giara K. Retinal Disease Therapies: What’s New and What’s Next. April 25, 2025. Available at https://www.medcentral.com/ophthalmology/retinal-disease-longer-acting-anti-vegf-therapies

Giara K. FDA Denies Approval for Reproxalap for Dry Eye Disease. April 3, 2025. Available at https://www.medcentral.com/ophthalmology/fda-decision-on-reproxalap-for-dry-eye-disease

Mitchell MT, Spence S (Medical Writing: Giara K, Winters B). Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care. March 31, 2025. Available at https://www.pharmacytimes.org/courses/revolutionizing-acute-pain-relief-emerging-nonopioid-therapies-and-the-essential-role-of-managed-care (Expires March 10, 2026)

Giara K. 5-in-1 Meningococcal Vaccination: A Clinical Advancement with an Unclear Future. March 27, 2025. Available at https://www.medcentral.com/infect-dis/new-meningococcal-vaccination-a-clinical-advancement-with-an-unclear-future

Giara K. Gepotidacin for UTI: A New Solution for an Age-Old Problem. March 26, 2025. Available at https://www.medcentral.com/internal-med/fda-decision-on-gepotidacin-antibiotic-for-uti

 Giara K. Intranasal Etripamil Could Reduce ED Utilization for PSVT. March 3, 2025. Available at http://medcentral.com/cardiology/FDA-decision-on-intranasal-etripamil-for-psvt

Giara K. Eyes on the Pipeline: Drugs to Watch in 2025. February 4, 2025. Available at https://www.medcentral.com/meds/2025-new-drug-pipeline-to-watch

Giara K. Ask the PharmD: How do I select the best targeted therapy to treat my patient with IBD? January 31, 2025. Available at https://www.medcentral.com/gastroenterology/how-do-i-select-the-best-targeted-therapy-to-treat-my-patient-with-ibd

Giara K. Suzetrigine’s Approval Signals a Shift in Non-Opioid Pain Management. January 30, 2025. Available at https://www.medcentral.com/pain/suzetrigine-pending-approval-signals-a-shift-in-non-opioid-pain-management

Melamed I. (Medical writer: Kelsey Giara). Gut Check: Pharmacists’ Guide to Navigating Prebiotics, Probiotics, and Postbiotics for Overall Health. January 29, 2025. Available at https://www.powerpak.com/course/preamble/125748 (Expires January 29, 2026)

Giara K. FDA Greenlights Monthly Lecanemab Dosing for Alzheimer’s. January 27, 2025. Available at https://www.medcentral.com/neurology/dementia/fda-lecanemab-monthly-maintenance-dosing-for-alzheimers

Giara K. Zepbound Approval a First for Obstructive Sleep Apnea. January 2, 2025. Available at https://www.medcentral.com/pulmonology/zepbound-label-expansion-could-broaden-the-sleep-apnea-armamentarium

Giara K. FDA Rejects Sotagliflozin for Type 1 Diabetes and CKD. December 20, 2024. Available at https://www.medcentral.com/endocrinology/diabetes/type-1/sotagliflozin-could-be-first-oral-therapy-for-type-1-diabetes

Giara K. Nemolizumab is the First IL-31 Inhibitor for Atopic Dermatitis. December 16, 2024. Available at https://www.medcentral.com/dermatology/atopic-dermatitis/nemolizumab-in-line-to-be-the-first-il-31-inhibitor-for-atopic-dermatitis

Giara K. Patient Safety: Cheers to the Beers: Unpacking the Latest Updates for Safer Prescribing. Presented live December 13, 2024. UConn School of Pharmacy Henry A. Palmer CE Finale.

Giara K. Ask the PharmD: What’s New in Antibiotics? December 5, 2024. Available at https://www.medcentral.com/infectious/whats-new-in-antibiotics

Giara K. Contraceptive Conversations: Pharmacists as Partners in Birth Control Prescribing. (State of Connecticut-approved pharmacist contraceptive prescribing training). November 27, 2024. Available at https://pharmacy.uconn.edu/course/bcp-2/ (Expires November 27, 2024)

Giara K. Why is the FDA considering a change to OTC decongestants? November 13, 2024. Available at https://www.medcentral.com/pulmonology/why-is-the-fda-considering-a-change-to-otc-decongestants

Giara K. Heart to Heart: Outpatient Medication Management in Heart Failure. October 26, 2024. Available at https://rxce.com/Outpatient-Med-Management-in-Heart-Failure-Pharmacist-ACPE-CEU (Expires October 26, 2027)

Clements JN (Medical Writing: Giara K). Embracing the Evolving Era of Pharmacotherapy in Obesity Management: Pharmacist Viewpoints on Unbiased, Data-Driven Treatment with Novel Agents. September 30, 2024. Available at https://www.powerpak.com/course/preamble/125379 (Expires September 30, 2025) 

Giara K. FDA Approves Dupixent as First Biologic for COPD Maintenance. September 27, 2024. Available at https://www.medcentral.com/pulmonology/fda-approves-dupixent-as-first-biologic-for-copd-maintenance

Giara K. Ask the PharmD: What should I know about the latest Beers Criteria for medication use in older adults? September 23, 2024. Available at https://www.medcentral.com/meds/what-should-i-know-about-the-latest-beers-criteria-for-medication-use-in 

Giara K. FDA Expands Guselkumab’s Indication for Treatment of Ulcerative Colitis. September 12, 2024. Available at https://www.medcentral.com/gastroenterology/fda-expands-guselkumabs-indication-for-induction-and-maintenance-treatment

Giara K. Ask the PharmD: What are the pros and cons of continuous glucose monitoring? August 29, 2024. Available at https://www.medcentral.com/endocrinology/diabetes/what-are-the-pros-and-cons-of-continuous-glucose-monitoring

Bauer M, Spence S (Medical Writing: Giara K, Smalley E). Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape. August 23, 2024. Available at https://www.pharmacytimes.org/courses/managed-care-insights-on-the-advances-in-the-eosinophilic-esophagitis-treatment-landscape (Expires August 23, 2025)

Giara K. Ask the PharmD: What’s New in Sleep Medicine? August 13, 2024. Available at https://www.medcentral.com/behavioral-mental/sleep-disorders/whats-new-in-sleep-medicine

Treatment Guide for Omalizumab (Xolair) for Asthma. August 5, 2024. Available at https://www.medcentral.com/drugs/guide/omalizumab-asthma

Giara K. Alpha Cognition’s New Alzheimer’s Drug Could Improve Tolerability for Patients. July 29, 2024. Available at https://www.medcentral.com/neurology/dementia/alpha-cognitions-new-alzheimers-drug-could-improve-tolerability-for-patients

Patient Guide to Lunsumio (Mosunetuzumab-axgb) for Follicular Lymphoma. July 23, 2024. Available at https://www.patientpower.info/drugs/guide/lunsumio-mosunetuzumab-axgb-for-follicular-lymphoma

Patient Guide to Polivy (Polatuzumab Vedotin-piiq) for DLBCL or HGBL. July 23, 2024. Available at https://www.patientpower.info/drugs/guide/polivy-for-dlbcl-or-hgbl

Giara K. FDA Approves Non-Steroidal Roflumilast Cream for Atopic Dermatitis. July 9, 2024. Available at https://www.medcentral.com/dermatology/fda-approves-non-steroidal-roflumilast-cream-for-atopic-dermatitis

Giara K. FDA Follows Advisory Committee's Vote in Favor of Donanemab for Alzheimer’s Disease. July 9, 2024. Available at https://www.medcentral.com/neurology/ dementia/fda-advisory-committee-votes-in-favor-of-eli-lillys-donanemab-for-alzheimers

Treatment Guide for Capivasertib (Truqap) for Breast Cancer. July 1, 2024. Available at https://www.oncologynewscentral.com/drugs/guide/capivasertib-breast-cancer

Giara K. CDC Advisory Committee Changes RSV Vaccination Approach: What to Tell Patients. June 27, 2024. Available at https://www.medcentral.com/infectious/cdc-advisory-committee-changes-rsv-vaccination-approach-what-to-tell

Giara K. FDA Expands Indication for GSK’s RSV Vaccine to Adults in 50s. June 27, 2024. Available at https://www.medcentral.com/infectious/fda-expands-indication-for-gsks-rsv-vaccine

Giara K. FDA Approves Moderna’s mRESVIA for Prevention of Severe Outcomes in Older Adults with RSV. June 27, 2024. Available at https://www.medcentral.com/infectious/ fda-approves-moderna-mresvia-vaccine-for-prevention-of-severe-outcomes-in-older-adults-with-rsv

Giara K. FDA Approves Merck's 21-Valent Pneumococcal Vaccine. June 18, 2024. Available at https://www.medcentral.com/pulmonology/fda-approves-merck-capvaxive-pneumococcal-vaccine-for-adults

Giara K. A New Spin on Mixology: Mechanisms and Consequences of Drug-Alcohol Interactions. May 26, 2024. Available at https://rxce.com/Drug-Alcohol-Interactions-Pharmacist-ACPE-CEU

Patient Guide to Columvi (Glofitamab-gxbm) for DLBCL and LBCL. May 8, 2024. Available at https://www.patientpower.info/drugs/guide/columvi-glofitamab-gxbm-for-dlbcl-and-lbcl

Giara K. Ask the PharmD: Which GLP-1 agonist, if any, is right for my patient? May 7, 2024. Available at https://www.medcentral.com/meds/which-glp-1-agonist-if-any-is-right-for-my-patient

Giara K. FDA Makes New UTI Med Available in US, May Aid E. Coli-Based Infections. April 25, 2024. Available at https://www.medcentral.com/urology/fda-makes-new-uti-med-available-in-us-may-aid-e-coli-infections

Giara K. Ask the PharmD: Are compounded medications truly safe for my patients? April 22, 2024. Available at https://www.medcentral.com/meds/are-compounded-medications-truly-safe-for-my-patients

Patient Guide to Brukinsa (Zanubrutinib) for CLL/SLL and MCL. April 19, 2024. Available at https://www.patientpower.info/drugs/guide/brukinsa-zanubrutinib-for-cll-sll-and-mcl

Patient Guide to Ojjaara (Momelotinib) for Myelofibrosis. April 11, 2024. Available at https://www.patientpower.info/drugs/guide/ojjaara-momelotinib-for-myelofibrosis

Patient Guide to Calquence (Acalabrutinib) for CLL/SLL and MCL. April 5, 2024. Available at https://www.patientpower.info/drugs/guide/calquence-acalabrutinib-for-cll-sll-and-mcl

Giara K. Ensifentrine May Fulfill Unmet Needs in COPD Maintenance Therapy. April 1, 2024. Available at https://www.medcentral.com/pulmonology/ensifentrine-may-fulfill-unmet-needs-in-copd-maintenance-therapy

Patient Guide to Venclexta (Venetoclax) for CLL/SLL and AML. March 28, 2024. Available at https://www.patientpower.info/drugs/guide/venetoclax-venclexta-for-cll-sll-and-aml

Giara K. The Semaglutide Saga: Turning Tides in Obesity, Diabetes, and Kidney Care. March 26, 2024. Available at https://www.medcentral.com/endocrinology/diabetes/type-2/the-semaglutide-saga-turning-tides-in-obesity-diabetes-and-kidney-care

Giara K. Ask the PharmD: Over-the-Counter Birth Control Pill: How to Answer Patient Questions. March 25, 2024. Available at https://www.medcentral.com/meds/over-the-counter-birth-control-pill-how-to-answer-patient-questions

Patient Guide to Jaypirca (Pirtobrutinib) for MCL and CLL/SLL. March 21, 2024. Available at https://www.patientpower.info/drugs/guide/pirtobrutinib-for-mcl-and-cll-sll

Giara K. Gastroenterology Drug Report: New and Notable Approvals. March 12, 2024. Available at https://www.medcentral.com/gastroenterology/gastroenterology-drug-report-new-and-notable-approvals

Giara K. Ask the PharmD: What information should I include on a topical prescription? March 1, 2024. Available at https://www.medcentral.com/dermatology/what-information-should-i-include-on-a-topical-prescription

Giara K. Ask the PharmD: Can a pharmacist change my prescription? February 20, 2024. Available at https://www.medcentral.com/meds/what-can-a-pharmacist-substitute-based-on-the-prescription-i-write

Giara K. Ask the PharmD: When to Escalate a Patient’s Medication Regimen. February 5, 2024. Available at https://www.medcentral.com/meds/adherence/how-do-i-address-adherence-before-adding-a-new-therapy-to-a-patients-regimen

Giara K. Aura You Ready: The Pharmacy Team’s Role in Migraine Management. February 2, 2024. Available at https://rxce.com/Pharmacy-Team-Role-in-Migraine-Management-Pharmacist-ACPE-CEU. (Expires February 2, 2027)

Patient Guide to Vonjo (Pacritinib) for Myelofibrosis. January 31, 2024. Available at https://www.patientpower.info/drugs/guide/pacritinib-for-myelofibrosis

Patient Guide to Carvykti (Ciltacabtagene Autoleucel) for Multiple Myeloma. January 23, 2024. Available at https://www.patientpower.info/drugs/guide/carvykti-for-multiple-myeloma

Giara K. Atopic Dermatitis Guideline Update Addresses Five Major Questions. January 9, 2024. Available at https://www.medcentral.com/dermatology/atopic-dermatitis-guideline-update-addresses-five-major-questions

Giara K. Ask the PharmD: What strategies can be used to counter steroid phobia in patients being treated for skin conditions? January 9, 2024. Available at https://www.medcentral.com/dermatology/what-strategies-can-be-used-to-counter-steroid-phobia-in-patients-being

Brittain K, Schneider S, Giara K. Respiratory Syncytial Virus in the Adult Population: Pharmacists’ and Pharmacy Technicians’ Important Roles in Promoting Prevention Through Vaccination. December 29, 2023. Available at https://www.powerpak.com/course/preamble/124507. (Expires December 29, 2024)

Giara K. Ask the PharmD: How can I reassure patients hesitant to take mRNA vaccines? December 28, 2023. Available at https://www.medcentral.com/infectious/covid/how-can-i-reassure-patients-hesitant-to-take-mrna-vaccines

Giara K. Indication Deviation in Women’s Health: Off-Label Drug Use from Conception to Menopause. Presented live December 15, 2023. UConn School of Pharmacy Henry A. Palmer CE Finale.

Giara K. FDA Approves Two Novel Gene Therapies for Sickle Cell Disease. December 8, 2023. Available at https://www.medcentral.com/cancer-blood-disorders/fda-approves-two-novel-gene-therapies-for-sickle-cell-disease

Giara K. Ask the PharmD: How can I choose the best statin for primary prevention of cardiovascular disease? December 2, 2023. Available at https://www.medcentral.com/cardiology/how-can-i-choose-the-best-statin-for-primary-prevention-of-cardiovascular-disease

Giara K. Shaping Futures: Pharmacy's Role in Pediatric Obesity. November 18, 2023. Available at https://rxce.com/Shaping-Futures-Pharmacys-Role-in-Pediatric-Obesity-Pharmacist-ACPE-CEU. (Expires November 18, 2026)

Giara K. FDA Approves Tirzepatide for Chronic Weight Management. November 9, 2023. Available at https://www.medcentral.com/endocrinology/obesity/fda-approves-tirzepatide-for-chronic-weight-management

Giara K. Ask the PharmD: How can I combat antibiotic resistance in my patients? November 8, 2023. Available at https://www.medcentral.com/meds/what-can-i-do-to-combat-antibiotic-resistance-in-my-patients

Giara K. Ask the PharmD: When is serotonin syndrome a serious concern? October 19, 2023. Available at https://www.medcentral.com/meds/when-is-serotonin-syndrome-a-serious-concern

Giara K. Ask the PharmD: How do I calculate my patient’s basal and bolus insulin needs? September 14, 2023. Available at https://www.medcentral.com/endocrinology/diabetes/how-do-i-calculate-my-patients-basal-and-bolus-insulin-needs

Giara K. Ask the PharmD: Which pneumococcal vaccine is right for my adult patient? September 14, 2023. Available at https://www.medcentral.com/infectious/how-do-i-know-which-pneumococcal-vaccine-my-adult-patient-is-indicated-for

Giara K. Ask the PharmD: How do I select the best antibiotic to optimize my patient’s UTI treatment? September 13, 2023. Available at https://www.medcentral.com/routine-care/how-do-i-select-the-best-antibiotic-to-optimize-my-patients-uti-treatment

Giara K. Combating moderate-to-severe pediatric atopic dermatitis: considerations for pharmacists. May 31, 2023. Available at https://www.powerpak.com/course/ preamble/123877. (Expires May 31, 2024)

Giara K. How to approach mental healthcare in adolescents. May 25, 2023. Available at https://pro.psycom.net/how-to-approach-mental-healthcare-in-adolescents.

Giara K. Law: Tic-toc, turn back the clock: Pharmacy in the post-Roe v. Wade climate. Presented live December 16, 2022. UConn School of Pharmacy Henry A. Palmer CE Finale.

Giara K. Only skin deep: The pharmacist’s guide to intradermal vaccine administration. December 5, 2022. Available at https://pharmacy.uconn.edu/course/itradermalvaccineadmin/. (Expires December 5, 2025)

Giara K. Medical writing: For pharmacy professionals who have a way with words. Presented live September 22, 2022. Connecticut Pharmacists Association (CPA) 2022 Annual Conference.

Giara K. Sjogren's syndrome: How dry am I? July 1, 2022. Available at https://pharmacy.uconn.edu/course/sjogrens-syndrome-how-dry-am-i/#. (Expires July 1, 2024)

Atta MG, Giara K. More than just blood in the urine: Recognizing and treating IgA nephropathy. May 13, 2022. Available at https://learning.freecme.com/a/39631P2E7uAy. (Expires May 13, 2023)

Giara K, Maroney M. Advancements in safe and effective treatment for bipolar I disorder. January 31, 2022. Available at https://www.pharmacytimes.org/courses/advancements-in-safe-and-effective-treatment-for-bipolar-i-disorder. (Expires March 15, 2023)

Giara K. Boosting the chances of conception: Fertility medications and the pharmacist. Presented live December 17, 2021. UConn School of Pharmacy Henry A. Palmer CE Finale. Available at https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2021/11/HO-6-per-page-Fertility.pdf

Giara K. My goodness, mycosis: Diagnosis and treatment of superficial fungal infections. December 15, 2021. Available at https://www.powerpak.com/course/preamble/122292. (Expires December 15, 2024)

Giara K. It’s all in your head: Self-treatment of headache. September 24, 2021. Available at https://www.powerpak.com/course/preamble/121942. (Expires September 24, 2022)

Giara K. The A-B-C’s of kids and medication: Re-schooling pharmacists and families for best outcomes. August 15, 2021. Available at https://pharmacy.uconn.edu/course/the-a-b-cs-of-kids-and-medication-re-schooling-pharmacists-and-families-for-best-outcomes/. (Expires August 15, 2024)

Giara K. From “splish-splash” to bicycle crash: A review of summer first aid. August 4, 2021. Available at https://www.powerpak.com/course/preamble/121538. (Expires August 4, 2024)

Giara K. Too much fun in the sun: Dispelling myths about sunburn prevention and treatment. July 23, 2021. Available at https://www.powerpak.com/course/preamble/121473. (Expires July 23, 2024)

Giara K. When critters bite: The community pharmacy team’s guide to insect-borne illnesses. July 21, 2021. Available at https://www.powerpak.com/course/preamble/121469. (Expires July 21, 2024) 

Giara K. Conceiving confidence: Maximizing the pharmacy team’s role in infertility treatment. May 26, 2021. Available at https://www.powerpak.com/course/preamble/121314. (Expires May 26, 2024)

Giara K. A team-based approach to combatting dry eye disease. April 30, 2021. Available at https://www.powerpak.com/course/preamble/121133. (Expires April 30, 2022)

Giara K. Spot heart failure a mile away. Pharmacy Times 2021;87(1): https://www.pharmacytimes.com/publications/issue/2021/january2021/spot-heart-failure-a-mile-away.

Giara K, Wick JY. Fundamentals of writing. UConn Medical Writing Certificate Program. December 1, 2020. Available at https://pharmacy.uconn.edu/continuing-pharmacy-education/ce-master-list/#umwc. (Expires November 30, 2023)

Giara K, Narayanan B. Continuing pharmacy and medical education. UConn Medical Writing Certificate Program. December 1, 2020. Available at https://pharmacy.uconn.edu/continuing-pharmacy-education/ce-master-list/#umwc. (Expires November 30, 2023)

Giara K. Pregnancy prevention in the new decade: Pharmacy professional roles in an evolving contraceptive landscape. November 5, 2020. Available at https://www.powerpak.com/course/preamble/120589. (Expires November 5, 2023)

Giara K. Vaccination as a key component of healthy aging: Focus on herpes zoster. September 30, 2020. Available at https://www.powerpak.com/course/preamble/120297. (Expires September 30, 2021)

Giara K, Wick JY. Most erectile dysfunction is treatable. Pharmacy Times 2020;86(9): https://www.pharmacytimes.com/publications/issue/2020/septembe2020/most-erectile-dysfunction-is-treatable.

Giara K. Contact lenses: Choosing the right solutions. September 30, 2020. Available at https://www.powerpak.com/course/preamble/120275. (Expires September 30, 2021)

Aeschlimann JR, Giara K, White CM. UConn UPDATE #1: SARS-CoV-2 and COVID-19. March 28, 2020. Available at https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/12/CORONAVIRUS-UPDATE-1-4DEC2020.pdf. (Expires December 31, 2021)

Giara K, Wick JY. When is a "whoop" not a cheer? Pharmacy Times 2019;85(11): 26-27.

Giara K, Wick JY. Choosing the best medication for diabetes is tricky. Pharmacy Times 2019;85(10): https://www.pharmacytimes.com/publications/issue/2019/october2019/choosing-the-best-medication-for-diabetes-is-tricky.

Giara K. Proficient in Parkinson’s: Understanding symptoms, patient impact, and medication advancements. September 15, 2019. Available at https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/02/Parkinsons-Disease-SEP2019-FINAL-3.pdf. (Expires September 15, 2021)

Giara K. Special considerations for special conditions: The community pharmacist’s guide tospecialty medications. July 15, 2019. Available at https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/02/Specialty-at-retail-JUL2019-FINAL.pdf. (Expires July 15, 2021) 

Giara K. Changing perspectives on contraceptives: The pharmacist’s guide to prescribing & counseling on birth control. December 15, 2018. Available at https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2021/02/Contraceptives-DEC2021-Updated-FINAL.pdf. (Expires December 14, 2021)

Hutchinson* K. Diabetes dialogue for patient safety: Talking with patients and prescribers. February 15, 2018. Available at https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/08/Patient-Safety-Diabetes-FEB2018-FINAL-extended.pdf. (Expires February 14, 2021)

Hutchinson K. The A-B-C’s of kids and medication: Re-schooling pharmacists and families forbest outcomes. September 15, 2017. (Expires September 15, 2019)

Hutchinson K, Wick JY. Deep brain stimulation and medication management in Parkinson's Disease. Consult Pharm. 2016;31(2):73-84.

Hutchinson K. Interprofessional education: What the textbooks and lectures didn't teach me. Pharmacy Careers 2015;81(11). Available at https://www.pharmacytimes.com/publications/career/2015/pharmacycareers_november2015/interprofessional-education-what-the-textbooks-and-lectures-didnt-teach-me.

Hutchinson K. Clinical pharmacists can identify PPI misuse. Pharmacy Times. October 10, 2015. Available at https://www.pharmacytimes.com/resource-centers/gastrointestinal/clinical-pharmacists-can-identify-ppi-misuse.

*Maiden name: Hutchinson